An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease
Calhoun A, King C, Khoury R, Grossberg GT. An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease. Expert Opinion On Pharmacotherapy 2018, 19: 1711-1717. PMID: 30244611, DOI: 10.1080/14656566.2018.1519022.Peer-Reviewed Original ResearchConceptsAlzheimer's diseaseNMDA receptor antagonist memantineSafety/tolerability dataDisease-modifying treatmentsSevere Alzheimer's diseaseCommon neurodegenerative diseaseMemantine ERTolerability dataTreatment regimenMedication adherenceCombination therapyPoor adherenceCaregiver burdenSocietal burdenDose combinationWarrants further considerationDrug AdministrationCaregiver supportCholinesterase inhibitorsPatientsDonepezilLiterature searchMemantineDiseaseNeurodegenerative diseases